Categories AlphaGraphs, Earnings, Health Care
Highlights of Bristol-Myers Squibb Company (NYSE: BMY) Q2 2020 Earnings
Pharmaceutical firm Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2020 financial results on Thursday morning. The results were better than analysts’ expectations.
Revenues surged 61% to $10.13 billion and adjusted earnings moved up to $1.63 per share from $1.18 per share in the second quarter of 2019. On a reported basis, the company posted a loss of $0.04 per share, compared to earnings of $0.87 per share last year.
“Our second quarter results reflect the passion and focus of our employees, who continue to introduce new medicines, support patients with serious diseases and deliver strong results during the COVID-19 pandemic,” said CEO Giovanni Caforio.
BMY shares rose 5% immediately after the earnings announcement during Thursday’s pre-market trading, after closing the previous session higher. The stock has gained 26% in the past 12 months.
Most Popular
Earnings Preview: Accenture (ACN) likely had a strong start to fiscal 2025
For Accenture plc. (NYSE: ACN), 2024 was a fruitful year marked by positive financial performance. The professional service firm effectively navigated a challenging market environment leveraging its agile business model
Signet Jewelers (SIG): Fashion remains a strong point for the jewelery retailer
Shares of Signet Jewelers Limited (NYSE: SIG) were down over 3% on Tuesday. The stock has dropped 12% over the past three months. The company faced challenges in the third
Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance
Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025. The company said it achieved the goal of $4 bln
